Inventor · disambiguated record
Mark Arnold Thomas Blaskovich
Also filed as: BLASKOVICH MARK · BLASKOVICH MARK A · BLASKOVICH MARK ARNOLD THOMAS
10 granted patents·5 pending applications·13 citations·filing 2003–2018
81Inventor score
Files withMIMETICA PTY LTD5CEPTYR INC3UNIV QUEENSLAND3BLASKOVICH MARK ARNOLD THOMAS2MYRIAD GENETICS INC2
Top patents by PatentIndex Score
15 records- 0181US7504389B2Protein tyrosine phosphatase inhibitors and methods of use thereofCEPTYR INC·Filed 2005·Granted Mar 17, 2009·7 cites·11 claims
- 0275US7829737B2Protein tyrosine phosphatase inhibitors and methods of use thereofCEPTYR INC·Filed 2008·Granted Nov 9, 2010·2 cites·3 claims
- 0369US8377925B2Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptorMIMETICA PTY LTD·Filed 2009·Granted Feb 19, 2013·1 cites·28 claims
- 0464US8008291B23-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonistsMIMETICA PTY LTD·Filed 2009·Granted Aug 30, 2011·1 cites·17 claims
- 0564US7053214B2β-sheet mimetics and composition and methods relating theretoMYRIAD GENETICS INC·Filed 2003·Granted May 30, 2006·2 cites·30 claims
- 0660US2009131374A1Protein tyrosine phosphatase inhibitors and methods of use thereofCEPTYR INC·Filed 2009·Application pending·0 cites
- 0753US9340517B2Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptorMIMETICA PTY LTD·Filed 2013·Granted May 17, 2016·0 cites·19 claims
- 0850US2006084653A1Beta-sheet mimetics and composition and methods relating theretoMYRIAD GENETICS INC·Filed 2005·Application pending·0 cites
- 0947US2012141392A1Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptorBLASKOVICH MARK ARNOLD THOMAS·Filed 2009·Application pending·0 cites
- 1045US2014128380A1Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptorMIMETICA PTY LTD·Filed 2014·Application pending·0 cites
- 1139US8440653B23-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonistsBLASKOVICH MARK ARNOLD THOMAS·Filed 2009·Granted May 14, 2013·0 cites·19 claims
- 1238US2020078466A1Glycopeptide antibiotic constructsUNIV QUEENSLAND·Filed 2017·Application pending·0 cites
- 1337US11279733B2Peptide antibioticsUNIV QUEENSLAND·Filed 2018·Granted Mar 22, 2022·0 cites·20 claims
- 1435US10947271B2Antibacterial agentsUNIV QUEENSLAND·Filed 2015·Granted Mar 16, 2021·0 cites·23 claims
- 1534US8343958B23-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonistsMIMETICA PTY LTD·Filed 2011·Granted Jan 1, 2013·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Mark Arnold Thomas Blaskovich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →